Multi-Constrained Evolutionary Molecular Design Framework: An Interpretable Drug Design Method Combining Rule-Based Evolution and Molecular Crossover
1. The study introduces MCEMOL, a novel framework for molecular optimization that integrates rule-based evolution with molecular crossover, offering an interpretable and efficient approach to drug design. Unlike traditional deep learning methods, MCEMOL requires minimal computational resources and evolves from a small number of starting molecules.
2. MCEMOL employs a dual-layer evolutionary strategy, optimizing transformation rules at the rule level while applying crossover and mutation to molecular structures. This dual approach ensures high molecular validity, diversity, and drug-likeness compliance, achieving 100% validity in generated molecules.
3. The framework incorporates a comprehensive chemical constraint system and message-passing neural networks to guide molecular optimization. It balances interpretability with generation performance, providing transparent design pathways through its evolutionary mechanism.
4. MCEMOL demonstrates strong performance in symmetry constraints, pharmacophore optimization, and stereochemical integrity. It delivers dual outputs: interpretable transformation rules that researchers can understand and trust, and a high-quality molecular library ready for practical applications.
5. Experimental results show that MCEMOL outperforms existing methods in terms of novelty, diversity, and drug-likeness while maintaining high interpretability. The framework is computationally efficient, making it accessible for resource-limited research settings.
šPaper:
arxiv.org/abs/2601.10110v1
#MolecularDesign #DrugDiscovery #EvolutionaryAlgorithm #InterpretableAI #ComputationalBiology